These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22656865)

  • 1. Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial.
    Van Parijs H; Miedema G; Vinh-Hung V; Verbanck S; Adriaenssens N; Kerkhove D; Reynders T; Schuermans D; Leysen K; Hanon S; Van Camp G; Vincken W; Storme G; Verellen D; De Ridder M
    Radiat Oncol; 2012 Jun; 7():80. PubMed ID: 22656865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy.
    Versmessen H; Vinh-Hung V; Van Parijs H; Miedema G; Voordeckers M; Adriaenssens N; Storme G; De Ridder M
    BMC Cancer; 2012 Oct; 12():495. PubMed ID: 23098579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiopulmonary-related patient-reported outcomes in a randomized clinical trial of radiation therapy for breast cancer.
    Van Parijs H; Vinh-Hung V; Fontaine C; Storme G; Verschraegen C; Nguyen DM; Adriaenssens N; Nguyen NP; Gorobets O; De Ridder M
    BMC Cancer; 2021 Nov; 21(1):1177. PubMed ID: 34736429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
    Yadav BS; Sharma SC
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern India.
    Nandi M; Mahata A; Mallick I; Achari R; Chatterjee S
    Asian Pac J Cancer Prev; 2014; 15(6):2505-10. PubMed ID: 24761855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years.
    Pinnarò P; Soriani A; Landoni V; Giordano C; Papale M; Marsella A; Marucci L; Arcangeli G; Strigari L
    J Exp Clin Cancer Res; 2010 Jan; 29(1):9. PubMed ID: 20100335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
    Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
    Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer.
    Krug D; Köder C; Häfner MF; Arians N; Harrabi SB; Koerber SA; Forster T; Schlampp I; Sohn C; Heil J; Hof H; Hörner-Rieber J; Debus J
    Radiat Oncol; 2020 Oct; 15(1):235. PubMed ID: 33050920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial.
    Chatterjee S; Chakraborty S;
    Trials; 2020 Sep; 21(1):819. PubMed ID: 32998747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
    Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
    Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
    Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
    Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer.
    Chadha M; Vongtama D; Friedmann P; Parris C; Boolbol SK; Woode R; Harrison LB
    Clin Breast Cancer; 2012 Feb; 12(1):57-62. PubMed ID: 22056970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
    King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
    Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge.
    Zwicker F; Hoefel S; Kirchner C; Huber PE; Debus J; Schempp M
    Anticancer Res; 2021 Apr; 41(4):1909-1920. PubMed ID: 33813396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.
    Wang SL; Fang H; Hu C; Song YW; Wang WH; Jin J; Liu YP; Ren H; Liu J; Li GF; Du XH; Tang Y; Jing H; Ma YC; Huang Z; Chen B; Tang Y; Li N; Lu NN; Qi SN; Yang Y; Sun GY; Liu XF; Li YX
    J Clin Oncol; 2020 Nov; 38(31):3604-3614. PubMed ID: 32780661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated and hypofractionated simultaneous integrated boost adjuvant breast radiation employing statics ports of tomotherapy (TomoDirect): a prospective phase II trial.
    Franco P; Zeverino M; Migliaccio F; Cante D; Sciacero P; Casanova Borca V; Torielli P; Arrichiello C; Girelli G; La Porta MR; Tofani S; Numico G; Ricardi U
    J Cancer Res Clin Oncol; 2014 Jan; 140(1):167-77. PubMed ID: 24292425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer.
    Cante D; Petrucci E; Sciacero P; Piva C; Ferrario S; Bagnera S; Patania S; Mondini G; Pasquino M; Casanova Borca V; Vellani G; La Porta MR; Franco P
    Med Oncol; 2017 Sep; 34(9):152. PubMed ID: 28776318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMRT sparing of normal tissues in locoregional treatment of breast cancer.
    Caudrelier JM; Meng J; Esche B; Grimard L; Ruddy T; Amjadi K
    Radiat Oncol; 2014 Jul; 9():161. PubMed ID: 25052720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cosmetic results of breast boost radiotherapy in early breast cancer: a randomized study between electron and photon.
    Rajan SS; Sharma SC; Kumar N; Kumar R; Singh G; Singh R; Tomar P
    J Cancer Res Ther; 2014; 10(4):889-95. PubMed ID: 25579524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.